Zobrazeno 1 - 10
of 49
pro vyhledávání: '"Ahmed Elkhanany"'
Autor:
Ameer Mansur, Moozhan Nikpanah, Johnathan McConathy, Erica Stringer-Reasor, Gabrielle Rocque, Ahmed Elkhanany, Katia Khoury, Nusrat Jahan, Suzanne E. Lapi, Anna G. Sorace
Publikováno v:
Journal of Clinical and Translational Science, Vol 8, Pp 139-139 (2024)
OBJECTIVES/GOALS: This study was performed to explore the capabilities of simultaneous [89 Zr]trastuzumab-PET/MRI acquisition in a cohort of metastatic HER2+ breast cancer. The insights derived provide additional noninvasive characterization and prec
Externí odkaz:
https://doaj.org/article/effaf72b545b453f872f48743d8b9f08
Autor:
Neelima Vidula, Andrew Lipman, Shumei Kato, Caroline Weipert, Katherine Hesler, Georges Azzi, Ahmed Elkhanany, Dejan Juric, Estelamari Rodriguez, Colleen Faulkner, Paul Makhlouf, Kristin Price, Joyce O’Shaughnessy, Aditya Bardia
Publikováno v:
npj Breast Cancer, Vol 8, Iss 1, Pp 1-7 (2022)
Abstract We evaluate microsatellite instability-high (MSI-H) status with cell-free DNA (cfDNA) in metastatic breast cancer (MBC) and the association with clinico-genomic characteristics. Patients with MSI-H in cfDNA (Guardant360®, 74 gene next-gener
Externí odkaz:
https://doaj.org/article/f65bfda34691462a94c380daea7a2c6a
Autor:
Heather A. Parsons, Timothy Blewett, Xiangying Chu, Sainetra Sridhar, Katheryn Santos, Kan Xiong, Vandana Abramson, Ashka Patel, Ju Cheng, Adam M. Brufsky, Justin Rhoades, Jeremy Force, Ruolin Liu, Tiffany A. Traina, Lisa Carey, Mothaffar Rimawi, Ahmed Elkhanany, Vered Stearns, Jennifer M. Specht, Harold Burstein, Antonio C. Wolff, Eric Winer, Nabihah Tayob, Ian Krop, Todd Golub, Erica L. Mayer, Viktor Adalsteinsson
Publikováno v:
Cancer Research. 83:PD11-06
Background. Patients (pts) with early triple negative breast cancer (eTNBC) are at increased risk of breast cancer recurrence and death. Recent studies have focused on escalation of therapy, with current treatment standard of at least five drugs –
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c514faa25bf89ae79cd6e545d5bd35c9
https://doi.org/10.1158/1538-7445.sabcs22-pd11-06
https://doi.org/10.1158/1538-7445.sabcs22-pd11-06
Autor:
Jeffrey Franks, Nicole E. Caston, Ahmed Elkhanany, Travis Gerke, Andres Azuero, Gabrielle B. Rocque
Publikováno v:
Cancer Research. 83:P4-07
Purpose: There are multiple treatment options for patients with metastatic breast cancer (MBC); however, there is minimal data on the optimal sequencing. Furthermore, limited information is available to understand the influence of prior treatment dur
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3afd6a2ce13701b5f98417dafcbc62fe
https://doi.org/10.1158/1538-7445.sabcs22-p4-07-20
https://doi.org/10.1158/1538-7445.sabcs22-p4-07-20
Autor:
Mylin A. Torres, Kevin Kalinsky, Erica Stringer-Reasor, Ahmed Elkhanany, Jolinta Lin, David M. Schuster, Sarah Friend, Jeffrey Switchenko, Manali Bhave
Publikováno v:
Cancer Research. 83:OT2-10
Background Although immunotherapy (IO) in combination with chemotherapy has improved progression free and overall survival in patients with PD-L1+ metastatic triple negative breast cancer (mTNBC), prognosis remains poor. A potential therapeutic strat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2e58a5c0ada44e9fdd5b8491fc6937b8
https://doi.org/10.1158/1538-7445.sabcs22-ot2-10-03
https://doi.org/10.1158/1538-7445.sabcs22-ot2-10-03
Autor:
Jeffrey Franks, Nicole E. Caston, Ahmed Elkhanany, Travis Gerke, Andres Azuero, Gabrielle B. Rocque
Publikováno v:
Breast Cancer Research and Treatment. 197:673-681
Purpose Multiple treatment options exist for patients with metastatic breast cancer (MBC). However, limited information is available on the impact of prior treatment duration and class on survival outcome for novel therapies, such as cyclin-dependent
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f3666ac33f574f6f7eee967c5ca80c9
https://doi.org/10.1007/s10549-022-06823-w
https://doi.org/10.1007/s10549-022-06823-w
Publikováno v:
Cancer Research. 80:P2-10
BACKGROUND. Outcome of breast cancer (BC) in African American females (AA) remains worse than Caucasian females (CA) after accounting for socioeconomic factors and tumor characteristics. Heterogeneity of tumor immune microenvironment (TIME) compositi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a10de6de14e85d11f52c37316a66a4a2
https://doi.org/10.1158/1538-7445.sabcs19-p2-10-03
https://doi.org/10.1158/1538-7445.sabcs19-p2-10-03
Publikováno v:
American Society of Clinical Oncology Educational Book. :e29-e46
Persistent disparities in the burden of breast cancer between African Americans and White Americans have been documented over many decades. Features characterizing breast cancer in the African American community include a 40% higher mortality rate, y
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f248d0a261032d1f6fe6406a737826f2
https://doi.org/10.1200/edbk_319929
https://doi.org/10.1200/edbk_319929
Autor:
Jennifer K. Litton, Kenneth Offit, Christine Laronga, Matthew B. Yurgelun, Leigha Senter-Jamieson, Kristen M. Shannon, Ahmed Elkhanany, Beth Y. Karlan, Seema A. Khan, Susan M. Domchek, Kari B. Wisinski, Patricia I. Dickson, Gwen Reiser, Holly J. Pederson, Catherine Klein, Barbara S. Norquist, Mary B. Daly, Allison W. Kurian, Wendy Kohlmann, Carolyn S. Menendez, Jeffrey N. Weitzel, Mary A. Dwyer, Mollie L. Hutton, Susan Darlow, Kala Visvanathan, Sofia D. Merajver, Rebecca Shatsky, Myra J. Wick, Michael Goggins, Saundra S. Buys, Michael Berry, Susan Hatters Friedman, Julie S. Mak, Tuya Pal
Publikováno v:
Journal of the National Comprehensive Cancer Network. 19:77-102
The NCCN Guidelines for Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic focus primarily on assessment of pathogenic or likely pathogenic variants associated with increased risk of breast, ovarian, and pancreatic cancer and reco
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a9b57ad3ed257825a4301e48dcd971c4
https://doi.org/10.6004/jnccn.2021.0001
https://doi.org/10.6004/jnccn.2021.0001
Autor:
Mollie L. Hutton, Mary A. Dwyer, Catherine Klein, Robert Pilarski, Kala Visvanathan, Michael Goggins, Susan Darlow, Myra J. Wick, Carolyn S. Menendez, Jennifer K. Litton, Kenneth Offit, Gwen Reiser, Seema A. Khan, Holly J. Pederson, Matthew B. Yurgelun, Patricia I. Dickson, Mary B. Daly, Allison W. Kurian, Christine Laronga, Sofia D. Merajver, Kari B. Wisinski, Barbara S. Norquist, Michael Berry, Saundra S. Buys, Susan Hatters Friedman, Wendy Kohlmann, Jeffrey N. Weitzel, Julie S. Mak, Ahmed Elkhanany, Judy Garber, Kristen M. Shannon, Susan M. Domchek, Tuya Pal
Publikováno v:
Journal of the National Comprehensive Cancer Network. 18:380-391
The NCCN Guidelines for Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic provide recommendations for genetic testing and counseling for hereditary cancer syndromes, and risk management recommendations for patients who are diagno
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b39e974208603592707867505730eb8e
https://doi.org/10.6004/jnccn.2020.0017
https://doi.org/10.6004/jnccn.2020.0017